VISMODEGIB
| Brand name | ERIVEDGE |
|---|---|
| Active ingredient | VISMODEGIB |
| Strength | 150MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9278961 | December 2028 | use U-1825 |
| 7888364 | November 2028 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.